Advanced search
1 file | 213.68 KB

The Role of EUTox in Uremic Toxin Research

(2009) SEMINARS IN DIALYSIS. 22(4). p.323-328
Author
Organization
Abstract
In this publication, we review the activities of the European Uremic Toxin Work Group (EUTox) in the field of uremic toxin research. Founded in 1999 under the umbrella of the European Society of Artificial Organs (ESAO), and active since 2000, this group focuses essentially on questions related to solute retention and removal during chronic kidney disease, and on the deleterious impact of those solutes on biological ⁄ biochemical systems. As of January 1, 2009, the group hadmet 28 times; it organized the third meeting, ‘‘Uremic Toxins in Cardiovascular Disease,’’ which took place in October 2008 in Amiens, France. The current group is composed of 25 members belonging to 23 European research institutions. As of November 1, 2008, in total 69 papers had been published to which at least two different research groups belonging to EUTox have contributed in a collaborative effort. Of these, 40 papers were on original research and eight were specific EUTox reviews or position statements. A website (http://www.eutox. info) summarizes all relevant information concerning the work group. EUTox also developed an interactive uremic toxin database, where concentrations of known toxins are displayed, to be used by researchers in the field. In the future, EUTox intends to continue its focus on bench to bedside research with specific consideration of proteomics, metabonomics, secretomics, and genomics.
Keywords
P-CRESOL, GUANIDINO COMPOUNDS, HEMODIALYSIS-PATIENTS, IN-VITRO, OXIDATION PROTEIN PRODUCTS, CHRONIC KIDNEY-DISEASE, STAGE RENAL-DISEASE, E-DEFICIENT MICE, E KNOCKOUT MICE, URIDINE ADENOSINE-TETRAPHOSPHATE

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 213.68 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Vanholder, Raymond, O Abou-Deif, A Argiles, U Baurmeister, J Beige, Peter Brouckaert, Philippe Brunet, et al. 2009. “The Role of EUTox in Uremic Toxin Research.” Seminars in Dialysis 22 (4): 323–328.
APA
Vanholder, R., Abou-Deif, O., Argiles, A., Baurmeister, U., Beige, J., Brouckaert, P., Brunet, P., et al. (2009). The Role of EUTox in Uremic Toxin Research. SEMINARS IN DIALYSIS, 22(4), 323–328.
Vancouver
1.
Vanholder R, Abou-Deif O, Argiles A, Baurmeister U, Beige J, Brouckaert P, et al. The Role of EUTox in Uremic Toxin Research. SEMINARS IN DIALYSIS. MALDEN: WILEY-BLACKWELL PUBLISHING, INC; 2009;22(4):323–8.
MLA
Vanholder, Raymond, O Abou-Deif, A Argiles, et al. “The Role of EUTox in Uremic Toxin Research.” SEMINARS IN DIALYSIS 22.4 (2009): 323–328. Print.
@article{787949,
  abstract     = {In this publication, we review the activities of the European
Uremic Toxin Work Group (EUTox) in the field of uremic
toxin research. Founded in 1999 under the umbrella of the
European Society of Artificial Organs (ESAO), and active
since 2000, this group focuses essentially on questions related
to solute retention and removal during chronic kidney disease,
and on the deleterious impact of those solutes on biological {\textfractionsolidus}
biochemical systems. As of January 1, 2009, the group hadmet
28 times; it organized the third meeting, {\textquoteleft}{\textquoteleft}Uremic Toxins in
Cardiovascular Disease,{\textquoteright}{\textquoteright} which took place in October 2008 in
Amiens, France. The current group is composed of 25
members belonging to 23 European research institutions. As of
November 1, 2008, in total 69 papers had been published to
which at least two different research groups belonging to EUTox have contributed in a collaborative effort. Of these, 40
papers were on original research and eight were specific EUTox
reviews or position statements. A website (http://www.eutox.
info) summarizes all relevant information concerning the
work group. EUTox also developed an interactive uremic toxin
database, where concentrations of known toxins are displayed,
to be used by researchers in the field. In the future, EUTox
intends to continue its focus on bench to bedside research with
specific consideration of proteomics, metabonomics, secretomics, and genomics.},
  author       = {Vanholder, Raymond and Abou-Deif, O and Argiles, A and Baurmeister, U and Beige, J and Brouckaert, Peter and Brunet, Philippe and Cohen, G and De Deyn, PP and Drueke, TB and Fliser, D and Glorieux, Griet and Herget-Rosenthal, S and Horl, WH and Jankowski, J and Jorres, A and Massy, ZA and Mischak, H and Perna, AF and Rodriguez-Portillo, JM and Spasovski, G and Stegmayr, BG and Stenvinkel, P and Thornalley, PJ and Wanner, C and Wiecek, A},
  issn         = {0894-0959},
  journal      = {SEMINARS IN DIALYSIS},
  language     = {eng},
  number       = {4},
  pages        = {323--328},
  publisher    = {WILEY-BLACKWELL PUBLISHING, INC},
  title        = {The Role of EUTox in Uremic Toxin Research},
  url          = {http://dx.doi.org/10.1111/j.1525-139X.2009.00574.x},
  volume       = {22},
  year         = {2009},
}

Altmetric
View in Altmetric
Web of Science
Times cited: